Literature DB >> 21172549

Intrathoracic linear stapled esophagogastric anastomosis: an alternative to the end to end anastomosis.

Lyall A Gorenstein1, Marc Bessler, Joshua R Sonett.   

Abstract

Minimally invasive esophagectomy (MIE) is gradually gaining acceptance as an oncological sound procedure. The advantages of MIE arise from avoidance of a thoracotomy or laparotomy, resulting in decreased pulmonary morbidity and generally a faster recovery, yet not compromising the surgical benefit of esophagectomy in patients with cancer of the esophagus. No single technique of esophagectomy has proven itself superior to another from either an oncologic or survival perspective. The MIE is a technically demanding procedure that requires advanced endoscopic skills, especially when performing an intrathoracic anastomosis. We present an alternative intrathoracic anastomotic technique to the commonly performed EEA anastomosis.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21172549     DOI: 10.1016/j.athoracsur.2010.02.115

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

1.  Hybrid trans-thoracic esophagectomy with side-to-side stapled intra-thoracic esophagogastric anastomosis for esophageal cancer.

Authors:  Marco E Allaix; Fernando A Herbella; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2013-07-09       Impact factor: 3.452

2.  Uniportal video-assisted thoracic surgery for esophageal cancer.

Authors:  Hasan F Batirel
Journal:  J Vis Surg       Date:  2017-11-06

3.  Early experience and lessons learned in a new minimally invasive esophagectomy program.

Authors:  Benedetto Mungo; Anne O Lidor; Miloslawa Stem; Daniela Molena
Journal:  Surg Endosc       Date:  2015-06-27       Impact factor: 4.584

4.  Thoracoscopic side-to-side esophagogastrostomy by use of linear stapler-a simplified technique facilitating a minimally invasive Ivor-Lewis operation.

Authors:  Tomoyuki Irino; Jon A Tsai; Jessica Ericson; Magnus Nilsson; Lars Lundell; Ioannis Rouvelas
Journal:  Langenbecks Arch Surg       Date:  2016-03-09       Impact factor: 3.445

5.  Intrathoracic esophagogastric anastomosis using a linear stapler following minimally invasive esophagectomy in the prone position.

Authors:  Hiroshi Okabe; Eiji Tanaka; Shigeru Tsunoda; Kazutaka Obama; Yoshiharu Sakai
Journal:  J Gastrointest Surg       Date:  2012-08-22       Impact factor: 3.452

Review 6.  Minimally invasive and robotic Ivor Lewis esophagectomy.

Authors:  Lingling Huang; Mark Onaitis
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

7.  Minimally Invasive Ivor Lewis Esophagectomy with Linear Stapled Anastomosis Associated with Low Leak and Stricture Rates.

Authors:  Moshim Kukar; Kfir Ben-David; June S Peng; Kristopher Attwood; Ryan M Thomas; Mark Hennon; Chukwumere Nwogu; Steven N Hochwald
Journal:  J Gastrointest Surg       Date:  2019-07-16       Impact factor: 3.452

Review 8.  Minimally invasive intrathoracic anastomosis after Ivor Lewis esophagectomy for cancer: a review of transoral or transthoracic use of staplers.

Authors:  K W Maas; S S A Y Biere; J J G Scheepers; S S Gisbertz; V Turrado Turrado Rodriguez; D L van der Peet; M A Cuesta
Journal:  Surg Endosc       Date:  2012-02-01       Impact factor: 4.584

9.  Totally mechanical linear stapled anastomosis for minimally invasive Ivor Lewis esophagectomy: Operative technique and short-term outcomes.

Authors:  Hui-Jiang Gao; Ju-Wei Mu; Wei-Min Pan; Malcolm Brock; Mao-Long Wang; Bin Han; Kai Ma
Journal:  Thorac Cancer       Date:  2020-02-03       Impact factor: 3.500

10.  Modified reverse-puncture anastomotic technique vs. traditional technique for total minimally invasive Ivor-Lewis esophagectomy.

Authors:  Xiaokang Shen; Tianming Chen; Xiaoming Shi; Ming Zheng; Zhang Yan Zhou; Hai Tao Qiu; Jiawei Zhao; Peng Lu; Po Yang; Shilin Chen
Journal:  World J Surg Oncol       Date:  2020-12-09       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.